Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Dysregulated ac4C modification of mRNA in a mouse model of early stage Alzheimer's disease [mRNA-seq]

ABSTRACT: Dysregulated ac4C modification of mRNA in a mouse model of early stage Alzheimer's disease [mRNA-seq]

PROVIDER: PRJNA1183411 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR31272647_1.fastq.gz	Fastqsanger.gz
	SRR31272647_2.fastq.gz	Fastqsanger.gz
	SRR31272648_1.fastq.gz	Fastqsanger.gz
	SRR31272648_2.fastq.gz	Fastqsanger.gz
	SRR31272649_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Dysregulated ac4C modification of mRNA in a mouse model of early stage Alzheimer's disease.

Project description:In this study, ac4C modifications in mRNA were investigated using six-month-old 5×FAD transgenic mice, a widely recognized model of Alzheimer's disease, along with age- and sex-matched wild-type (WT) controls. To elucidate the role of ac4C-modified mRNA in AD, we employed three analytical techniques: acetylated RNA immunoprecipitation sequencing (ac4C-RIP-seq), RNA sequencing (RNA-seq), and proteomic analysis. The first two were used to identify mRNAs carrying ac4C modifications and to quantify mRNA abundance, respectively.

2025-01-02 | GSE285655 | GEO

Dysregulated ac4C modification of mRNA in a mouse model of early stage Alzheimer's disease [mRNA-seq]

Project description:In this study, ac4C modifications in mRNA were investigated using three-month-old 5×FAD transgenic mice, a widely recognized model of Alzheimer's disease, along with age- and sex-matched wild-type (WT) controls. To elucidate the role of ac4C-modified mRNA in AD, we employed three analytical techniques: acetylated RNA immunoprecipitation sequencing (ac4C-RIP-seq), RNA sequencing (RNA-seq), and proteomic analysis. The first two were used to identify mRNAs carrying ac4C modifications and to quantify mRNA abundance, respectively.

2024-11-12 | GSE281343 | GEO

Dysregulated ac4C modification of mRNA in a mouse model of early stage Alzheimer's disease [RNA-seq]

2025-01-11 | GSE286035 | GEO

Dysregulated ac4C modification of mRNA in a mouse model of early stage Alzheimer's disease [acRIP-seq]

2024-11-12 | GSE281676 | GEO

Dysregulated ac4C modification of mRNA in a mouse model of early stage Alzheimer's disease.

Project description:Dysregulated ac4C modification of mRNA in a mouse model of early stage Alzheimer's disease.

| PRJNA1205378 | ENA

Dysregulated ac4C modification of mRNA in a mouse model of early stage Alzheimer's disease [acRIP-seq]

Project description:Dysregulated ac4C modification of mRNA in a mouse model of early stage Alzheimer's disease [acRIP-seq]

| PRJNA1185211 | ENA

Dysregulated ac4C modification of mRNA in a mouse model of early stage Alzheimer's disease [RNA-seq]

Project description:Dysregulated ac4C modification of mRNA in a mouse model of early stage Alzheimer's disease [RNA-seq]

| PRJNA1207525 | ENA

chemical ac4C sequencing (ac4C-seq) to identify mRNA ac4C sites

Project description:NAT10-catalyzed N4-acetylcytidine (ac4C) has emerged as a vital post-transcriptional modulator on the coding transcriptome by promoting mRNA stability. To explore the transcriptome-wide profile of ac4C modification, we mapped the locations of ac4C modification on wild-type (WT) hESCs and NAT10 KD hESCs by NaCNBH3-based chemical ac4C sequencing (ac4C-seq).

2023-08-25 | GSE226747 | GEO

chemical ac4C sequencing (ac4C-seq) to identify mRNA ac4C sites

Project description:chemical ac4C sequencing (ac4C-seq) to identify mRNA ac4C sites

| PRJNA941322 | ENA

ac4C-RIP-seq to identify mRNA ac4C peaks

2023-08-25 | GSE226748 | GEO